J&J li­cens­es LegoChem's Trop2 ADC for $100M up­front

Last year
Deals

Bris­tol My­ers to buy Rayze­Bio for $4.1B as phar­ma piles in­to bur­geon­ing ra­dio­phar­ma field

Last year
Deals

AlloVir to wind down PhI­II tri­als for fu­til­i­ty and will re­view strate­gic al­ter­na­tives

Last year
R&D

Ab­b­Vie's $10B Im­muno­Gen deal was won by pay­ing $7 a share over a ri­val bid­der's of­fer, SEC fil­ings show

Last year
Deals

Bris­tol My­ers bets on neu­ro­science surge with $14B Karuna cash ac­qui­si­tion

Last year
Deals
Pharma

FDA ap­proves As­traZeneca, Ion­is' AT­TR drug as show­down with Al­ny­lam heats up

Last year
Pharma
FDA+

Cal­lid­i­tas wins full ap­proval for steroid drug in rare au­toim­mune dis­ease

Last year
Pharma
FDA+

Phar­ma com­pa­nies delist patents from FDA's Or­ange Book fol­low­ing FTC chal­lenges

Last year
Pharma
FDA+

FDA find­ings at Mod­er­na's Mass­a­chu­setts fa­cil­i­ty don't re­flect qual­i­ty, safe­ty con­cerns, com­pa­ny says

Last year
Pharma
FDA+

Servi­er found guilty of fraud in tri­al over pulled weight loss drug Me­di­a­tor, re­vers­ing ear­li­er rul­ing

Last year
Pharma
Law

Charles Riv­er to make Cas­gevy; Rentschler ex­tends col­lab with ‘ma­jor client’; An­de­lyn works with Ul­tragenyx

Last year
Manufacturing

Clene’s FDA up­date; JCR ends ties with Take­da, part­ners with As­traZeneca; Gilead ups stake in Hookipa

Last year
News Briefing

Tonix rais­es $144M in a di­rect of­fer­ing fol­low­ing pos­i­tive PhI­II da­ta for its fi­bromyal­gia drug

Last year
Financing
R&D

J&J buys eye dis­ease gene ther­a­py from MeiraGTx, giv­ing the biotech the cash in­fu­sion it was seek­ing

Last year
Deals
Cell/Gene Tx

Lil­ly part­ners with start­up Fau­na Bio to see if a squir­rel’s hi­ber­na­tion could lead to new obe­si­ty drugs

Last year
Startups
Deals

Bio­Marin strikes co­op­er­a­tion deal with ac­tivist in­vestor El­liott, sets up re­view com­mit­tee and adds board mem­bers

Last year
People
Pharma

Im­muno­vant un­veils pos­i­tive ear­ly da­ta for PhII Graves' dis­ease drug

Last year
R&D

FDA hands CRL to Mer­ck­'s chron­ic cough drug over ef­fi­ca­cy ques­tions

Last year
R&D
FDA+

Deck the halls with res­ig­na­tions: Lian­Bio CEO, CFO out; CRISPR Ther­a­peu­tics CMO to leave in Jan­u­ary

Last year
Peer Review

Sanofi pulls the plug on ADC af­ter lung can­cer PhI­II dis­ap­points

Last year
R&D

Bris­tol My­ers gets reg­u­la­to­ry clear­ance to close Mi­rati deal as FTC in­creas­es pres­sure on phar­ma M&A

Last year
Deals
Pharma

Ab­b­Vie files trade se­crets suit against Ad­cen­trx and for­mer em­ploy­ee

Last year
Pharma
Law

FDA to set up new Of­fice of the Chief Med­ical Of­fi­cer as part of agency reshuf­fling

Last year
Pharma
FDA+

Grail has big plans for its blood can­cer tests. The first step: Find­ing a new own­er

Last year
In Focus
Diagnostics
First page Previous page 226227228229230231232 Next page Last page
A service from the Financial Times